Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Veterinary Molecular Diagnostics Market Growth Potential: How Will Market Size Shift Through 2030?
The veterinary molecular diagnostics market has seen significant expansion over recent years. Its valuation is projected to rise from $0.7 billion in 2025 to $0.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. This historical growth can be linked to several factors including the increasing incidence of infectious and genetic animal diseases, breakthroughs in molecular biology technology, the growing populations of companion and livestock animals, elevated veterinary awareness and training initiatives, and the adoption of conventional molecular diagnostic kits.
The veterinary molecular diagnostics market is anticipated to experience substantial expansion over the coming years, with its valuation projected to reach $1.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period stems from factors such as increasing demand for swift and precise molecular diagnostics, the widespread adoption of NGS and high-throughput platforms, the broadening of veterinary genomics services, the incorporation of AI-driven diagnostic analysis, and an increasing focus on preventive veterinary care facilitated by molecular testing. Key developments expected in the forecast period encompass the proliferation of PCR and RT-PCR-based diagnostics, the rising uptake of next-generation sequencing (NGS) within veterinary medicine, the creation of multiplex diagnostic kits designed for infectious diseases, the seamless incorporation of molecular diagnostics into standard veterinary care, and the emergence of automated, high-throughput molecular testing solutions.
Get A Free Sample Report With In-Depth Market Insights:
Veterinary Molecular Diagnostics Market Growth Backed By Core Demand Fundamentals
The significant occurrence of zoonotic diseases is projected to drive the future growth of the veterinary molecular diagnostics market. These infectious diseases are transferred between animals and humans, and their causes can include bacteria, viruses, parasites, or fungi. Common examples of zoonotic diseases are rabies, Lyme disease, salmonellosis, and toxoplasmosis. The widespread nature of zoonotic diseases is influenced by factors like deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics aid in the early detection of these diseases in animals, which helps prevent their spread to humans. They also improve disease management by enabling the quick and accurate identification of pathogens. For instance, in December 2025, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, stated that in 2024, the reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to rise, indicating a notable ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is a key driver for the veterinary molecular diagnostics market.
Veterinary Molecular Diagnostics Market Segment Analysis: What Are The Core Market Categories?
The veterinary molecular diagnostics market covered in this report is segmented –
1) By Product: Kits And Reagents, Instruments
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Infectious Diseases, Genetic Diseases, Other Applications
4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users
Subsegments:
1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)
2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems
Veterinary Molecular Diagnostics Market Growth Trends Reshaping The Competitive Landscape
Major companies operating in the veterinary molecular diagnostics market are concentrating on automation and scalability in diagnostic technologies, such as high-volume testing machines, to improve diagnostic accuracy, increase testing efficiency, and enable faster detection of diseases in animals. High-volume testing machines are advanced diagnostic devices designed to process large quantities of samples efficiently, enabling rapid and accurate analysis in laboratories or clinical settings, particularly useful for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a cutting-edge molecular diagnostic testing device equipped with quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp. It greatly increases its testing capacity when paired with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines.
Veterinary Molecular Diagnostics Market Competitive Overview And Top Companies
Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.
View The Full Veterinary Molecular Diagnostics Market Report:
Veterinary Molecular Diagnostics Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
